• roche logo

The devil is in the details.

Get the facts. Know her risk.


Principal publications.

To obtain copies of manuscripts regarding HPV and clinical research, choose from the links below:

Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of High-risk HPV Positive Cytology Negative Women
Wright TC Jr, Stoler MH, Sharma A, Zhang G, Behrens CM, Wright TL. Am J Clin Pathol 2011; 136:578-586.

High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology. Results From the ATHENA HPV Study
Stoler MH, Wright TC Jr, Sharma A, Apple R, Gutekunst K, Wright TL. Am J Clin Pathol 2011; 135:468-475.

The Interplay of Age Stratification and HPV Testing on the Predictive Value of ASC-US Ctyology. Results from the ATHENA HPV Study
Stoler, MH, Wright TC Jr, Sharma A, Zhang G, Apple R, Wright TL, Behrens CM. Am J Clin Pathol 2012; 137:295-303.

The ATHENA human papillomavirus study: design, methods, and baseline results
Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL. Am J Obstet Gynecol 2011; in press.

Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study 

Cox JT, Castle PE, Behrens CM, et al. Am J Obstet Gynecol 2012; in press.

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study 

Castle PE, Stoler MH, Wright TC Jr., et al. Lancet Oncol 2011; Published Online August 23, 2011.